Related references
Note: Only part of the references are listed.Epidemiology of Peripheral Artery Disease
Michael H. Criqui et al.
CIRCULATION RESEARCH (2015)
The natural history of untreated severe or critical limb ischemia
Abd Moain Abu Dabrh et al.
JOURNAL OF VASCULAR SURGERY (2015)
Therapeutic Potential of MicroRNA Let-7: Tumor Suppression or Impeding Normal Stemness
Shao-Chih Chiu et al.
CELL TRANSPLANTATION (2014)
Let-7g Improves Multiple Endothelial Functions Through Targeting Transforming Growth Factor-Beta and SIRT-1 Signaling
Yi-Chu Liao et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
An antiangiogenic isoform of VEGF-A contributes to impaired vascularization in peripheral artery disease
Ryosuke Kikuchi et al.
NATURE MEDICINE (2014)
Meta-analysis of contemporary short- and long-term mortality rates in patients diagnosed with critical leg ischaemia
K. E. Rollins et al.
BRITISH JOURNAL OF SURGERY (2013)
Let-7 in Cardiovascular Diseases, Heart Development and Cardiovascular Differentiation from Stem Cells
Mei-Hua Bao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Hypoxia-responsive miRNAs target argonaute 1 to promote angiogenesis
Zhen Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Attenuation of Hind-Limb Ischemia in Mice with Endothelial-Like Cells Derived from Different Sources of Human Stem Cells
Wing-Hon Lai et al.
PLOS ONE (2013)
Gene Therapy and Cell-Based Therapies for Therapeutic Angiogenesis in Peripheral Artery Disease
Munehisa Shimamura et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Negative feedback regulation between microRNA let-7g and the oxLDL receptor LOX-1
Ku-Chung Chen et al.
JOURNAL OF CELL SCIENCE (2011)
Peripheral artery disease. Part 1: clinical evaluation and noninvasive diagnosis
Joe F. Lau et al.
NATURE REVIEWS CARDIOLOGY (2011)
Increased perfusion and angiogenesis in a hindlimb ischemia model with plasmid FGF-2 delivered by noninvasive electroporation
B. Ferraro et al.
GENE THERAPY (2010)
The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo
G. Merdzhanova et al.
ONCOGENE (2010)
Evaluation of postnatal arteriogenesis and angiogenesis in a mouse model of hind-limb ischemia
Anne Limbourg et al.
NATURE PROTOCOLS (2009)
E2F1 controls alternative splicing pattern of genes involved in apoptosis through upregulation of the splicing factor SC35
G. Merdzhanova et al.
CELL DEATH AND DIFFERENTIATION (2008)
VEGF-A splicing: the key to anti-angiogenic therapeutics?
Steven J. Harper et al.
NATURE REVIEWS CANCER (2008)
Inter-society consensus for the management of peripheral arterial disease (TASC II)
L. Norgren et al.
JOURNAL OF VASCULAR SURGERY (2007)
Cell cycle regulator E2F1 modulates angiogenesis via p53-dependent transcriptional control of VEGF
Gangjian Qin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Share Paper
